nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—AHR—stomach cancer	0.494	1	CbGaD
Leflunomide—ABCG2—Irinotecan—stomach cancer	0.0433	0.195	CbGbCtD
Leflunomide—ABCG2—Fluorouracil—stomach cancer	0.0415	0.187	CbGbCtD
Leflunomide—ABCG2—Docetaxel—stomach cancer	0.0317	0.143	CbGbCtD
Leflunomide—CYP2C9—Capecitabine—stomach cancer	0.026	0.117	CbGbCtD
Leflunomide—ABCG2—Doxorubicin—stomach cancer	0.0236	0.107	CbGbCtD
Leflunomide—ABCG2—Methotrexate—stomach cancer	0.0229	0.103	CbGbCtD
Leflunomide—CYP1A2—Fluorouracil—stomach cancer	0.0171	0.0773	CbGbCtD
Leflunomide—CYP2C9—Fluorouracil—stomach cancer	0.0154	0.0696	CbGbCtD
Leflunomide—DHODH—hematopoietic system—stomach cancer	0.00344	0.0966	CbGeAlD
Leflunomide—DHODH—lymphoid tissue—stomach cancer	0.00242	0.068	CbGeAlD
Leflunomide—PTK2B—hematopoietic system—stomach cancer	0.00218	0.0612	CbGeAlD
Leflunomide—DHODH—endocrine gland—stomach cancer	0.00197	0.0555	CbGeAlD
Leflunomide—PTK2B—smooth muscle tissue—stomach cancer	0.00192	0.0539	CbGeAlD
Leflunomide—DHODH—liver—stomach cancer	0.00178	0.0501	CbGeAlD
Leflunomide—AHR—smooth muscle tissue—stomach cancer	0.00158	0.0443	CbGeAlD
Leflunomide—PTK2B—lymphoid tissue—stomach cancer	0.00153	0.0431	CbGeAlD
Leflunomide—PTK2B—digestive system—stomach cancer	0.00151	0.0426	CbGeAlD
Leflunomide—AHR—pancreas—stomach cancer	0.00146	0.041	CbGeAlD
Leflunomide—PTK2B—bone marrow—stomach cancer	0.0014	0.0392	CbGeAlD
Leflunomide—DHODH—lymph node—stomach cancer	0.00136	0.0384	CbGeAlD
Leflunomide—PTK2B—endocrine gland—stomach cancer	0.00125	0.0352	CbGeAlD
Leflunomide—AHR—digestive system—stomach cancer	0.00124	0.035	CbGeAlD
Leflunomide—AHR—bone marrow—stomach cancer	0.00115	0.0323	CbGeAlD
Leflunomide—PTK2B—liver—stomach cancer	0.00113	0.0317	CbGeAlD
Leflunomide—AHR—endocrine gland—stomach cancer	0.00103	0.0289	CbGeAlD
Leflunomide—AHR—liver—stomach cancer	0.000927	0.0261	CbGeAlD
Leflunomide—PTK2B—lymph node—stomach cancer	0.000865	0.0243	CbGeAlD
Leflunomide—AHR—lymph node—stomach cancer	0.000711	0.02	CbGeAlD
Leflunomide—CYP1A2—hematopoietic system—stomach cancer	0.000668	0.0188	CbGeAlD
Leflunomide—CYP2C9—hematopoietic system—stomach cancer	0.000634	0.0178	CbGeAlD
Leflunomide—CYP1A2—digestive system—stomach cancer	0.000465	0.0131	CbGeAlD
Leflunomide—ABCG2—bone marrow—stomach cancer	0.000445	0.0125	CbGeAlD
Leflunomide—CYP2C9—digestive system—stomach cancer	0.000441	0.0124	CbGeAlD
Leflunomide—CYP1A2—endocrine gland—stomach cancer	0.000384	0.0108	CbGeAlD
Leflunomide—CYP2C9—endocrine gland—stomach cancer	0.000364	0.0102	CbGeAlD
Leflunomide—ABCG2—liver—stomach cancer	0.00036	0.0101	CbGeAlD
Leflunomide—CYP1A2—liver—stomach cancer	0.000346	0.00973	CbGeAlD
Leflunomide—CYP2C9—liver—stomach cancer	0.000328	0.00924	CbGeAlD
Leflunomide—ABCG2—lymph node—stomach cancer	0.000276	0.00775	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—stomach cancer	0.000223	1	CrCbGaD
Leflunomide—Immune system disorder—Methotrexate—stomach cancer	6.95e-05	0.000512	CcSEcCtD
Leflunomide—Dizziness—Fluorouracil—stomach cancer	6.95e-05	0.000512	CcSEcCtD
Leflunomide—Mediastinal disorder—Methotrexate—stomach cancer	6.94e-05	0.000511	CcSEcCtD
Leflunomide—Agranulocytosis—Doxorubicin—stomach cancer	6.93e-05	0.00051	CcSEcCtD
Leflunomide—Rash—Irinotecan—stomach cancer	6.92e-05	0.00051	CcSEcCtD
Leflunomide—Dermatitis—Irinotecan—stomach cancer	6.91e-05	0.000509	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.91e-05	0.000509	CcSEcCtD
Leflunomide—Chills—Methotrexate—stomach cancer	6.91e-05	0.000509	CcSEcCtD
Leflunomide—Headache—Irinotecan—stomach cancer	6.88e-05	0.000506	CcSEcCtD
Leflunomide—Hypotension—Capecitabine—stomach cancer	6.86e-05	0.000505	CcSEcCtD
Leflunomide—Insomnia—Docetaxel—stomach cancer	6.86e-05	0.000505	CcSEcCtD
Leflunomide—Paraesthesia—Docetaxel—stomach cancer	6.81e-05	0.000502	CcSEcCtD
Leflunomide—Erythema multiforme—Epirubicin—stomach cancer	6.81e-05	0.000501	CcSEcCtD
Leflunomide—Alopecia—Methotrexate—stomach cancer	6.8e-05	0.000501	CcSEcCtD
Leflunomide—Dyspnoea—Docetaxel—stomach cancer	6.76e-05	0.000498	CcSEcCtD
Leflunomide—Mental disorder—Methotrexate—stomach cancer	6.74e-05	0.000497	CcSEcCtD
Leflunomide—Eye disorder—Epirubicin—stomach cancer	6.73e-05	0.000496	CcSEcCtD
Leflunomide—Malnutrition—Methotrexate—stomach cancer	6.7e-05	0.000493	CcSEcCtD
Leflunomide—Haemoglobin—Doxorubicin—stomach cancer	6.7e-05	0.000493	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.69e-05	0.000493	CcSEcCtD
Leflunomide—Cardiac disorder—Epirubicin—stomach cancer	6.69e-05	0.000492	CcSEcCtD
Leflunomide—Vomiting—Fluorouracil—stomach cancer	6.68e-05	0.000492	CcSEcCtD
Leflunomide—Rhinitis—Doxorubicin—stomach cancer	6.68e-05	0.000492	CcSEcCtD
Leflunomide—Dyspepsia—Docetaxel—stomach cancer	6.68e-05	0.000492	CcSEcCtD
Leflunomide—Haemorrhage—Doxorubicin—stomach cancer	6.67e-05	0.000491	CcSEcCtD
Leflunomide—Hepatitis—Doxorubicin—stomach cancer	6.67e-05	0.000491	CcSEcCtD
Leflunomide—Insomnia—Capecitabine—stomach cancer	6.64e-05	0.000489	CcSEcCtD
Leflunomide—Rash—Fluorouracil—stomach cancer	6.63e-05	0.000488	CcSEcCtD
Leflunomide—Dermatitis—Fluorouracil—stomach cancer	6.62e-05	0.000488	CcSEcCtD
Leflunomide—Pharyngitis—Doxorubicin—stomach cancer	6.61e-05	0.000487	CcSEcCtD
Leflunomide—Paraesthesia—Capecitabine—stomach cancer	6.6e-05	0.000486	CcSEcCtD
Leflunomide—Decreased appetite—Docetaxel—stomach cancer	6.6e-05	0.000486	CcSEcCtD
Leflunomide—Headache—Fluorouracil—stomach cancer	6.59e-05	0.000485	CcSEcCtD
Leflunomide—Urinary tract disorder—Doxorubicin—stomach cancer	6.58e-05	0.000485	CcSEcCtD
Leflunomide—Oedema peripheral—Doxorubicin—stomach cancer	6.57e-05	0.000483	CcSEcCtD
Leflunomide—Dysgeusia—Methotrexate—stomach cancer	6.56e-05	0.000483	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Docetaxel—stomach cancer	6.55e-05	0.000482	CcSEcCtD
Leflunomide—Connective tissue disorder—Doxorubicin—stomach cancer	6.55e-05	0.000482	CcSEcCtD
Leflunomide—Dyspnoea—Capecitabine—stomach cancer	6.55e-05	0.000482	CcSEcCtD
Leflunomide—Fatigue—Docetaxel—stomach cancer	6.54e-05	0.000482	CcSEcCtD
Leflunomide—Urethral disorder—Doxorubicin—stomach cancer	6.53e-05	0.000481	CcSEcCtD
Leflunomide—Nausea—Irinotecan—stomach cancer	6.52e-05	0.00048	CcSEcCtD
Leflunomide—Immune system disorder—Epirubicin—stomach cancer	6.51e-05	0.000479	CcSEcCtD
Leflunomide—Mediastinal disorder—Epirubicin—stomach cancer	6.49e-05	0.000478	CcSEcCtD
Leflunomide—Constipation—Docetaxel—stomach cancer	6.49e-05	0.000478	CcSEcCtD
Leflunomide—Pain—Docetaxel—stomach cancer	6.49e-05	0.000478	CcSEcCtD
Leflunomide—Back pain—Methotrexate—stomach cancer	6.48e-05	0.000477	CcSEcCtD
Leflunomide—Dyspepsia—Capecitabine—stomach cancer	6.47e-05	0.000476	CcSEcCtD
Leflunomide—Chills—Epirubicin—stomach cancer	6.46e-05	0.000476	CcSEcCtD
Leflunomide—Arrhythmia—Epirubicin—stomach cancer	6.43e-05	0.000474	CcSEcCtD
Leflunomide—Decreased appetite—Capecitabine—stomach cancer	6.39e-05	0.00047	CcSEcCtD
Leflunomide—Alopecia—Epirubicin—stomach cancer	6.37e-05	0.000469	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Capecitabine—stomach cancer	6.34e-05	0.000467	CcSEcCtD
Leflunomide—Fatigue—Capecitabine—stomach cancer	6.33e-05	0.000466	CcSEcCtD
Leflunomide—Vision blurred—Methotrexate—stomach cancer	6.31e-05	0.000465	CcSEcCtD
Leflunomide—Mental disorder—Epirubicin—stomach cancer	6.31e-05	0.000465	CcSEcCtD
Leflunomide—Erythema multiforme—Doxorubicin—stomach cancer	6.3e-05	0.000464	CcSEcCtD
Leflunomide—Pain—Capecitabine—stomach cancer	6.28e-05	0.000463	CcSEcCtD
Leflunomide—Constipation—Capecitabine—stomach cancer	6.28e-05	0.000463	CcSEcCtD
Leflunomide—Malnutrition—Epirubicin—stomach cancer	6.27e-05	0.000462	CcSEcCtD
Leflunomide—Feeling abnormal—Docetaxel—stomach cancer	6.25e-05	0.00046	CcSEcCtD
Leflunomide—Nausea—Fluorouracil—stomach cancer	6.24e-05	0.00046	CcSEcCtD
Leflunomide—Eye disorder—Doxorubicin—stomach cancer	6.23e-05	0.000459	CcSEcCtD
Leflunomide—Ill-defined disorder—Methotrexate—stomach cancer	6.22e-05	0.000458	CcSEcCtD
Leflunomide—Gastrointestinal pain—Docetaxel—stomach cancer	6.2e-05	0.000457	CcSEcCtD
Leflunomide—Anaemia—Methotrexate—stomach cancer	6.19e-05	0.000456	CcSEcCtD
Leflunomide—Cardiac disorder—Doxorubicin—stomach cancer	6.19e-05	0.000455	CcSEcCtD
Leflunomide—Flatulence—Epirubicin—stomach cancer	6.18e-05	0.000455	CcSEcCtD
Leflunomide—Dysgeusia—Epirubicin—stomach cancer	6.14e-05	0.000452	CcSEcCtD
Leflunomide—Back pain—Epirubicin—stomach cancer	6.07e-05	0.000447	CcSEcCtD
Leflunomide—Feeling abnormal—Capecitabine—stomach cancer	6.05e-05	0.000446	CcSEcCtD
Leflunomide—Malaise—Methotrexate—stomach cancer	6.04e-05	0.000445	CcSEcCtD
Leflunomide—Muscle spasms—Epirubicin—stomach cancer	6.03e-05	0.000444	CcSEcCtD
Leflunomide—Immune system disorder—Doxorubicin—stomach cancer	6.02e-05	0.000443	CcSEcCtD
Leflunomide—Vertigo—Methotrexate—stomach cancer	6.02e-05	0.000443	CcSEcCtD
Leflunomide—Gastrointestinal pain—Capecitabine—stomach cancer	6.01e-05	0.000442	CcSEcCtD
Leflunomide—Mediastinal disorder—Doxorubicin—stomach cancer	6.01e-05	0.000442	CcSEcCtD
Leflunomide—Abdominal pain—Docetaxel—stomach cancer	6e-05	0.000442	CcSEcCtD
Leflunomide—Body temperature increased—Docetaxel—stomach cancer	6e-05	0.000442	CcSEcCtD
Leflunomide—Leukopenia—Methotrexate—stomach cancer	6e-05	0.000442	CcSEcCtD
Leflunomide—Chills—Doxorubicin—stomach cancer	5.98e-05	0.00044	CcSEcCtD
Leflunomide—Arrhythmia—Doxorubicin—stomach cancer	5.95e-05	0.000438	CcSEcCtD
Leflunomide—Vision blurred—Epirubicin—stomach cancer	5.91e-05	0.000435	CcSEcCtD
Leflunomide—Alopecia—Doxorubicin—stomach cancer	5.89e-05	0.000434	CcSEcCtD
Leflunomide—Cough—Methotrexate—stomach cancer	5.85e-05	0.000431	CcSEcCtD
Leflunomide—Mental disorder—Doxorubicin—stomach cancer	5.84e-05	0.00043	CcSEcCtD
Leflunomide—Urticaria—Capecitabine—stomach cancer	5.84e-05	0.00043	CcSEcCtD
Leflunomide—Ill-defined disorder—Epirubicin—stomach cancer	5.82e-05	0.000428	CcSEcCtD
Leflunomide—Abdominal pain—Capecitabine—stomach cancer	5.81e-05	0.000428	CcSEcCtD
Leflunomide—Body temperature increased—Capecitabine—stomach cancer	5.81e-05	0.000428	CcSEcCtD
Leflunomide—Malnutrition—Doxorubicin—stomach cancer	5.8e-05	0.000427	CcSEcCtD
Leflunomide—Anaemia—Epirubicin—stomach cancer	5.8e-05	0.000427	CcSEcCtD
Leflunomide—Flatulence—Doxorubicin—stomach cancer	5.72e-05	0.000421	CcSEcCtD
Leflunomide—Arthralgia—Methotrexate—stomach cancer	5.7e-05	0.00042	CcSEcCtD
Leflunomide—Chest pain—Methotrexate—stomach cancer	5.7e-05	0.00042	CcSEcCtD
Leflunomide—Myalgia—Methotrexate—stomach cancer	5.7e-05	0.00042	CcSEcCtD
Leflunomide—Dysgeusia—Doxorubicin—stomach cancer	5.68e-05	0.000418	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.67e-05	0.000417	CcSEcCtD
Leflunomide—Malaise—Epirubicin—stomach cancer	5.65e-05	0.000416	CcSEcCtD
Leflunomide—Discomfort—Methotrexate—stomach cancer	5.64e-05	0.000415	CcSEcCtD
Leflunomide—Vertigo—Epirubicin—stomach cancer	5.63e-05	0.000415	CcSEcCtD
Leflunomide—Leukopenia—Epirubicin—stomach cancer	5.61e-05	0.000413	CcSEcCtD
Leflunomide—Back pain—Doxorubicin—stomach cancer	5.61e-05	0.000413	CcSEcCtD
Leflunomide—Hypersensitivity—Docetaxel—stomach cancer	5.59e-05	0.000412	CcSEcCtD
Leflunomide—Muscle spasms—Doxorubicin—stomach cancer	5.58e-05	0.000411	CcSEcCtD
Leflunomide—Palpitations—Epirubicin—stomach cancer	5.54e-05	0.000408	CcSEcCtD
Leflunomide—Cough—Epirubicin—stomach cancer	5.47e-05	0.000403	CcSEcCtD
Leflunomide—Anaphylactic shock—Methotrexate—stomach cancer	5.47e-05	0.000403	CcSEcCtD
Leflunomide—Vision blurred—Doxorubicin—stomach cancer	5.47e-05	0.000403	CcSEcCtD
Leflunomide—Asthenia—Docetaxel—stomach cancer	5.44e-05	0.000401	CcSEcCtD
Leflunomide—Infection—Methotrexate—stomach cancer	5.43e-05	0.0004	CcSEcCtD
Leflunomide—Hypertension—Epirubicin—stomach cancer	5.41e-05	0.000399	CcSEcCtD
Leflunomide—Hypersensitivity—Capecitabine—stomach cancer	5.41e-05	0.000398	CcSEcCtD
Leflunomide—Ill-defined disorder—Doxorubicin—stomach cancer	5.38e-05	0.000396	CcSEcCtD
Leflunomide—Pruritus—Docetaxel—stomach cancer	5.37e-05	0.000395	CcSEcCtD
Leflunomide—Nervous system disorder—Methotrexate—stomach cancer	5.36e-05	0.000395	CcSEcCtD
Leflunomide—Anaemia—Doxorubicin—stomach cancer	5.36e-05	0.000395	CcSEcCtD
Leflunomide—Thrombocytopenia—Methotrexate—stomach cancer	5.35e-05	0.000394	CcSEcCtD
Leflunomide—Chest pain—Epirubicin—stomach cancer	5.34e-05	0.000393	CcSEcCtD
Leflunomide—Myalgia—Epirubicin—stomach cancer	5.34e-05	0.000393	CcSEcCtD
Leflunomide—Arthralgia—Epirubicin—stomach cancer	5.34e-05	0.000393	CcSEcCtD
Leflunomide—Anxiety—Epirubicin—stomach cancer	5.32e-05	0.000392	CcSEcCtD
Leflunomide—Skin disorder—Methotrexate—stomach cancer	5.31e-05	0.000391	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.3e-05	0.00039	CcSEcCtD
Leflunomide—Hyperhidrosis—Methotrexate—stomach cancer	5.29e-05	0.000389	CcSEcCtD
Leflunomide—Discomfort—Epirubicin—stomach cancer	5.27e-05	0.000388	CcSEcCtD
Leflunomide—Asthenia—Capecitabine—stomach cancer	5.27e-05	0.000388	CcSEcCtD
Leflunomide—Malaise—Doxorubicin—stomach cancer	5.23e-05	0.000385	CcSEcCtD
Leflunomide—Dry mouth—Epirubicin—stomach cancer	5.22e-05	0.000384	CcSEcCtD
Leflunomide—Vertigo—Doxorubicin—stomach cancer	5.21e-05	0.000384	CcSEcCtD
Leflunomide—Anorexia—Methotrexate—stomach cancer	5.21e-05	0.000384	CcSEcCtD
Leflunomide—Pruritus—Capecitabine—stomach cancer	5.2e-05	0.000383	CcSEcCtD
Leflunomide—Leukopenia—Doxorubicin—stomach cancer	5.19e-05	0.000382	CcSEcCtD
Leflunomide—Diarrhoea—Docetaxel—stomach cancer	5.19e-05	0.000382	CcSEcCtD
Leflunomide—Palpitations—Doxorubicin—stomach cancer	5.13e-05	0.000378	CcSEcCtD
Leflunomide—Anaphylactic shock—Epirubicin—stomach cancer	5.12e-05	0.000377	CcSEcCtD
Leflunomide—Hypotension—Methotrexate—stomach cancer	5.11e-05	0.000376	CcSEcCtD
Leflunomide—Infection—Epirubicin—stomach cancer	5.08e-05	0.000374	CcSEcCtD
Leflunomide—Cough—Doxorubicin—stomach cancer	5.06e-05	0.000373	CcSEcCtD
Leflunomide—Diarrhoea—Capecitabine—stomach cancer	5.03e-05	0.00037	CcSEcCtD
Leflunomide—Nervous system disorder—Epirubicin—stomach cancer	5.02e-05	0.00037	CcSEcCtD
Leflunomide—Dizziness—Docetaxel—stomach cancer	5.02e-05	0.000369	CcSEcCtD
Leflunomide—Thrombocytopenia—Epirubicin—stomach cancer	5.01e-05	0.000369	CcSEcCtD
Leflunomide—Hypertension—Doxorubicin—stomach cancer	5.01e-05	0.000369	CcSEcCtD
Leflunomide—Tachycardia—Epirubicin—stomach cancer	4.99e-05	0.000368	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.98e-05	0.000367	CcSEcCtD
Leflunomide—Skin disorder—Epirubicin—stomach cancer	4.97e-05	0.000366	CcSEcCtD
Leflunomide—Hyperhidrosis—Epirubicin—stomach cancer	4.95e-05	0.000364	CcSEcCtD
Leflunomide—Insomnia—Methotrexate—stomach cancer	4.95e-05	0.000364	CcSEcCtD
Leflunomide—Arthralgia—Doxorubicin—stomach cancer	4.94e-05	0.000364	CcSEcCtD
Leflunomide—Myalgia—Doxorubicin—stomach cancer	4.94e-05	0.000364	CcSEcCtD
Leflunomide—Chest pain—Doxorubicin—stomach cancer	4.94e-05	0.000364	CcSEcCtD
Leflunomide—Anxiety—Doxorubicin—stomach cancer	4.92e-05	0.000362	CcSEcCtD
Leflunomide—Paraesthesia—Methotrexate—stomach cancer	4.91e-05	0.000362	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.91e-05	0.000361	CcSEcCtD
Leflunomide—Discomfort—Doxorubicin—stomach cancer	4.88e-05	0.000359	CcSEcCtD
Leflunomide—Anorexia—Epirubicin—stomach cancer	4.88e-05	0.000359	CcSEcCtD
Leflunomide—Dyspnoea—Methotrexate—stomach cancer	4.88e-05	0.000359	CcSEcCtD
Leflunomide—Dizziness—Capecitabine—stomach cancer	4.86e-05	0.000358	CcSEcCtD
Leflunomide—Dry mouth—Doxorubicin—stomach cancer	4.83e-05	0.000356	CcSEcCtD
Leflunomide—Vomiting—Docetaxel—stomach cancer	4.82e-05	0.000355	CcSEcCtD
Leflunomide—Dyspepsia—Methotrexate—stomach cancer	4.81e-05	0.000354	CcSEcCtD
Leflunomide—Rash—Docetaxel—stomach cancer	4.78e-05	0.000352	CcSEcCtD
Leflunomide—Hypotension—Epirubicin—stomach cancer	4.78e-05	0.000352	CcSEcCtD
Leflunomide—Dermatitis—Docetaxel—stomach cancer	4.78e-05	0.000352	CcSEcCtD
Leflunomide—Decreased appetite—Methotrexate—stomach cancer	4.75e-05	0.00035	CcSEcCtD
Leflunomide—Headache—Docetaxel—stomach cancer	4.75e-05	0.00035	CcSEcCtD
Leflunomide—Anaphylactic shock—Doxorubicin—stomach cancer	4.74e-05	0.000349	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Methotrexate—stomach cancer	4.72e-05	0.000348	CcSEcCtD
Leflunomide—Fatigue—Methotrexate—stomach cancer	4.71e-05	0.000347	CcSEcCtD
Leflunomide—Infection—Doxorubicin—stomach cancer	4.7e-05	0.000346	CcSEcCtD
Leflunomide—Pain—Methotrexate—stomach cancer	4.68e-05	0.000344	CcSEcCtD
Leflunomide—Vomiting—Capecitabine—stomach cancer	4.67e-05	0.000344	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.66e-05	0.000343	CcSEcCtD
Leflunomide—Nervous system disorder—Doxorubicin—stomach cancer	4.64e-05	0.000342	CcSEcCtD
Leflunomide—Thrombocytopenia—Doxorubicin—stomach cancer	4.64e-05	0.000341	CcSEcCtD
Leflunomide—Rash—Capecitabine—stomach cancer	4.63e-05	0.000341	CcSEcCtD
Leflunomide—Insomnia—Epirubicin—stomach cancer	4.63e-05	0.000341	CcSEcCtD
Leflunomide—Dermatitis—Capecitabine—stomach cancer	4.63e-05	0.000341	CcSEcCtD
Leflunomide—Tachycardia—Doxorubicin—stomach cancer	4.62e-05	0.00034	CcSEcCtD
Leflunomide—Headache—Capecitabine—stomach cancer	4.6e-05	0.000339	CcSEcCtD
Leflunomide—Skin disorder—Doxorubicin—stomach cancer	4.6e-05	0.000339	CcSEcCtD
Leflunomide—Paraesthesia—Epirubicin—stomach cancer	4.6e-05	0.000338	CcSEcCtD
Leflunomide—Hyperhidrosis—Doxorubicin—stomach cancer	4.58e-05	0.000337	CcSEcCtD
Leflunomide—Dyspnoea—Epirubicin—stomach cancer	4.56e-05	0.000336	CcSEcCtD
Leflunomide—Anorexia—Doxorubicin—stomach cancer	4.51e-05	0.000332	CcSEcCtD
Leflunomide—Nausea—Docetaxel—stomach cancer	4.51e-05	0.000332	CcSEcCtD
Leflunomide—Feeling abnormal—Methotrexate—stomach cancer	4.51e-05	0.000332	CcSEcCtD
Leflunomide—Dyspepsia—Epirubicin—stomach cancer	4.5e-05	0.000332	CcSEcCtD
Leflunomide—Gastrointestinal pain—Methotrexate—stomach cancer	4.47e-05	0.000329	CcSEcCtD
Leflunomide—Decreased appetite—Epirubicin—stomach cancer	4.45e-05	0.000328	CcSEcCtD
Leflunomide—Hypotension—Doxorubicin—stomach cancer	4.42e-05	0.000326	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Epirubicin—stomach cancer	4.42e-05	0.000325	CcSEcCtD
Leflunomide—Fatigue—Epirubicin—stomach cancer	4.41e-05	0.000325	CcSEcCtD
Leflunomide—Pain—Epirubicin—stomach cancer	4.38e-05	0.000322	CcSEcCtD
Leflunomide—Constipation—Epirubicin—stomach cancer	4.38e-05	0.000322	CcSEcCtD
Leflunomide—Nausea—Capecitabine—stomach cancer	4.36e-05	0.000321	CcSEcCtD
Leflunomide—Urticaria—Methotrexate—stomach cancer	4.34e-05	0.00032	CcSEcCtD
Leflunomide—Abdominal pain—Methotrexate—stomach cancer	4.32e-05	0.000318	CcSEcCtD
Leflunomide—Body temperature increased—Methotrexate—stomach cancer	4.32e-05	0.000318	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.31e-05	0.000318	CcSEcCtD
Leflunomide—Insomnia—Doxorubicin—stomach cancer	4.28e-05	0.000315	CcSEcCtD
Leflunomide—Paraesthesia—Doxorubicin—stomach cancer	4.25e-05	0.000313	CcSEcCtD
Leflunomide—Dyspnoea—Doxorubicin—stomach cancer	4.22e-05	0.000311	CcSEcCtD
Leflunomide—Feeling abnormal—Epirubicin—stomach cancer	4.22e-05	0.000311	CcSEcCtD
Leflunomide—Gastrointestinal pain—Epirubicin—stomach cancer	4.18e-05	0.000308	CcSEcCtD
Leflunomide—Dyspepsia—Doxorubicin—stomach cancer	4.17e-05	0.000307	CcSEcCtD
Leflunomide—Decreased appetite—Doxorubicin—stomach cancer	4.12e-05	0.000303	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.09e-05	0.000301	CcSEcCtD
Leflunomide—Fatigue—Doxorubicin—stomach cancer	4.08e-05	0.000301	CcSEcCtD
Leflunomide—Urticaria—Epirubicin—stomach cancer	4.07e-05	0.000299	CcSEcCtD
Leflunomide—Constipation—Doxorubicin—stomach cancer	4.05e-05	0.000298	CcSEcCtD
Leflunomide—Pain—Doxorubicin—stomach cancer	4.05e-05	0.000298	CcSEcCtD
Leflunomide—Abdominal pain—Epirubicin—stomach cancer	4.05e-05	0.000298	CcSEcCtD
Leflunomide—Body temperature increased—Epirubicin—stomach cancer	4.05e-05	0.000298	CcSEcCtD
Leflunomide—Hypersensitivity—Methotrexate—stomach cancer	4.03e-05	0.000297	CcSEcCtD
Leflunomide—Asthenia—Methotrexate—stomach cancer	3.92e-05	0.000289	CcSEcCtD
Leflunomide—Feeling abnormal—Doxorubicin—stomach cancer	3.9e-05	0.000287	CcSEcCtD
Leflunomide—Gastrointestinal pain—Doxorubicin—stomach cancer	3.87e-05	0.000285	CcSEcCtD
Leflunomide—Pruritus—Methotrexate—stomach cancer	3.87e-05	0.000285	CcSEcCtD
Leflunomide—Hypersensitivity—Epirubicin—stomach cancer	3.77e-05	0.000278	CcSEcCtD
Leflunomide—Urticaria—Doxorubicin—stomach cancer	3.76e-05	0.000277	CcSEcCtD
Leflunomide—Body temperature increased—Doxorubicin—stomach cancer	3.74e-05	0.000276	CcSEcCtD
Leflunomide—Abdominal pain—Doxorubicin—stomach cancer	3.74e-05	0.000276	CcSEcCtD
Leflunomide—Diarrhoea—Methotrexate—stomach cancer	3.74e-05	0.000275	CcSEcCtD
Leflunomide—Asthenia—Epirubicin—stomach cancer	3.67e-05	0.00027	CcSEcCtD
Leflunomide—Pruritus—Epirubicin—stomach cancer	3.62e-05	0.000267	CcSEcCtD
Leflunomide—Dizziness—Methotrexate—stomach cancer	3.62e-05	0.000266	CcSEcCtD
Leflunomide—Diarrhoea—Epirubicin—stomach cancer	3.5e-05	0.000258	CcSEcCtD
Leflunomide—Hypersensitivity—Doxorubicin—stomach cancer	3.49e-05	0.000257	CcSEcCtD
Leflunomide—Vomiting—Methotrexate—stomach cancer	3.48e-05	0.000256	CcSEcCtD
Leflunomide—Rash—Methotrexate—stomach cancer	3.45e-05	0.000254	CcSEcCtD
Leflunomide—Dermatitis—Methotrexate—stomach cancer	3.44e-05	0.000254	CcSEcCtD
Leflunomide—Headache—Methotrexate—stomach cancer	3.43e-05	0.000252	CcSEcCtD
Leflunomide—Asthenia—Doxorubicin—stomach cancer	3.4e-05	0.00025	CcSEcCtD
Leflunomide—Dizziness—Epirubicin—stomach cancer	3.38e-05	0.000249	CcSEcCtD
Leflunomide—Pruritus—Doxorubicin—stomach cancer	3.35e-05	0.000247	CcSEcCtD
Leflunomide—Vomiting—Epirubicin—stomach cancer	3.25e-05	0.00024	CcSEcCtD
Leflunomide—Nausea—Methotrexate—stomach cancer	3.25e-05	0.000239	CcSEcCtD
Leflunomide—Diarrhoea—Doxorubicin—stomach cancer	3.24e-05	0.000239	CcSEcCtD
Leflunomide—Rash—Epirubicin—stomach cancer	3.23e-05	0.000238	CcSEcCtD
Leflunomide—Dermatitis—Epirubicin—stomach cancer	3.22e-05	0.000237	CcSEcCtD
Leflunomide—Headache—Epirubicin—stomach cancer	3.21e-05	0.000236	CcSEcCtD
Leflunomide—Dizziness—Doxorubicin—stomach cancer	3.13e-05	0.000231	CcSEcCtD
Leflunomide—Nausea—Epirubicin—stomach cancer	3.04e-05	0.000224	CcSEcCtD
Leflunomide—Vomiting—Doxorubicin—stomach cancer	3.01e-05	0.000222	CcSEcCtD
Leflunomide—Rash—Doxorubicin—stomach cancer	2.99e-05	0.00022	CcSEcCtD
Leflunomide—Dermatitis—Doxorubicin—stomach cancer	2.98e-05	0.00022	CcSEcCtD
Leflunomide—Headache—Doxorubicin—stomach cancer	2.97e-05	0.000218	CcSEcCtD
Leflunomide—Nausea—Doxorubicin—stomach cancer	2.81e-05	0.000207	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—GSTP1—stomach cancer	2.4e-05	0.000212	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	2.36e-05	0.000209	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CKB—stomach cancer	2.34e-05	0.000208	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CA1—stomach cancer	2.34e-05	0.000208	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NDUFA2—stomach cancer	2.34e-05	0.000208	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—FBP1—stomach cancer	2.34e-05	0.000208	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PPP2R1A—stomach cancer	2.3e-05	0.000204	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	2.21e-05	0.000196	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—PIK3CA—stomach cancer	2.2e-05	0.000195	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLIN2—stomach cancer	2.2e-05	0.000195	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTM1—stomach cancer	2.2e-05	0.000195	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	2.17e-05	0.000192	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	2.16e-05	0.000191	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	2.16e-05	0.000191	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	2.16e-05	0.000191	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CA2—stomach cancer	2.14e-05	0.00019	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	2.14e-05	0.000189	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PGAM1—stomach cancer	2.09e-05	0.000185	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NT5E—stomach cancer	2.09e-05	0.000185	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HSPB1—stomach cancer	2.08e-05	0.000184	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AGTR2—stomach cancer	2.08e-05	0.000184	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ACAD8—stomach cancer	2.06e-05	0.000183	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—BMP2—stomach cancer	2.06e-05	0.000182	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—F2R—stomach cancer	2.06e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	2.06e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	2.06e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTP1—stomach cancer	2.05e-05	0.000181	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	2.04e-05	0.000181	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HRAS—stomach cancer	2.04e-05	0.000181	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FYN—stomach cancer	2.03e-05	0.00018	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKR1C3—stomach cancer	2.02e-05	0.000179	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	2.02e-05	0.000179	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	2.01e-05	0.000178	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR1A—stomach cancer	2e-05	0.000177	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLCE1—stomach cancer	1.99e-05	0.000176	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALDH7A1—stomach cancer	1.99e-05	0.000176	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—stomach cancer	1.95e-05	0.000173	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ANXA1—stomach cancer	1.94e-05	0.000171	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—UMPS—stomach cancer	1.91e-05	0.000169	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FGFR2—stomach cancer	1.9e-05	0.000169	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	1.89e-05	0.000168	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTM1—stomach cancer	1.88e-05	0.000167	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB1—stomach cancer	1.87e-05	0.000166	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	1.86e-05	0.000164	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GMPR2—stomach cancer	1.84e-05	0.000163	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RPS6—stomach cancer	1.79e-05	0.000159	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PDHA1—stomach cancer	1.78e-05	0.000157	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ECHS1—stomach cancer	1.78e-05	0.000157	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	1.77e-05	0.000157	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ACAD8—stomach cancer	1.76e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	1.75e-05	0.000155	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRS2—stomach cancer	1.74e-05	0.000154	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	1.73e-05	0.000154	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	1.72e-05	0.000152	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.71e-05	0.000151	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SUCLG1—stomach cancer	1.68e-05	0.000149	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—IDH3B—stomach cancer	1.68e-05	0.000149	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—FADS1—stomach cancer	1.67e-05	0.000148	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TYMP—stomach cancer	1.67e-05	0.000148	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HBEGF—stomach cancer	1.65e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	1.62e-05	0.000143	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PRKCB—stomach cancer	1.61e-05	0.000143	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6ST—stomach cancer	1.6e-05	0.000142	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PIK3CA—stomach cancer	1.6e-05	0.000142	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GMPR2—stomach cancer	1.57e-05	0.000139	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SREBF2—stomach cancer	1.56e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NDUFV1—stomach cancer	1.56e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NDUFS1—stomach cancer	1.56e-05	0.000138	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—RORA—stomach cancer	1.54e-05	0.000137	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.53e-05	0.000135	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB2—stomach cancer	1.52e-05	0.000134	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	1.52e-05	0.000134	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	1.5e-05	0.000133	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PPP2R1A—stomach cancer	1.49e-05	0.000132	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALDOB—stomach cancer	1.45e-05	0.000128	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—IDH3B—stomach cancer	1.44e-05	0.000127	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SUCLG1—stomach cancer	1.44e-05	0.000127	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CASP8—stomach cancer	1.43e-05	0.000127	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6R—stomach cancer	1.43e-05	0.000127	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CDH1—stomach cancer	1.42e-05	0.000126	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—BLVRB—stomach cancer	1.39e-05	0.000123	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PGLS—stomach cancer	1.39e-05	0.000123	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SMAD4—stomach cancer	1.38e-05	0.000122	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALOX5—stomach cancer	1.35e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NDUFV1—stomach cancer	1.33e-05	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NDUFS1—stomach cancer	1.33e-05	0.000118	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPAP2A—stomach cancer	1.33e-05	0.000118	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DPYD—stomach cancer	1.32e-05	0.000117	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FYN—stomach cancer	1.31e-05	0.000116	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.3e-05	0.000116	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—APOA1—stomach cancer	1.3e-05	0.000115	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.28e-05	0.000113	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGFR2—stomach cancer	1.23e-05	0.000109	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ERBB2—stomach cancer	1.2e-05	0.000106	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—BLVRB—stomach cancer	1.19e-05	0.000105	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PGLS—stomach cancer	1.19e-05	0.000105	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FBP1—stomach cancer	1.18e-05	0.000105	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.18e-05	0.000105	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CKB—stomach cancer	1.18e-05	0.000105	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA1—stomach cancer	1.18e-05	0.000105	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTT1—stomach cancer	1.17e-05	0.000104	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2A6—stomach cancer	1.16e-05	0.000103	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPAP2A—stomach cancer	1.13e-05	0.000101	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IRS2—stomach cancer	1.13e-05	9.99e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKR1C3—stomach cancer	1.13e-05	9.97e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLIN2—stomach cancer	1.11e-05	9.86e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CDKN1B—stomach cancer	1.11e-05	9.81e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ENO1—stomach cancer	1.1e-05	9.72e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CAV1—stomach cancer	1.09e-05	9.69e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.09e-05	9.66e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOA1—stomach cancer	1.09e-05	9.66e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—stomach cancer	1.09e-05	9.64e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA2—stomach cancer	1.08e-05	9.59e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PGAM1—stomach cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NT5E—stomach cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—JUN—stomach cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PRKCB—stomach cancer	1.04e-05	9.22e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6ST—stomach cancer	1.04e-05	9.18e-05	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—stomach cancer	1.03e-05	9.09e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CDKN1A—stomach cancer	1.02e-05	9.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CKB—stomach cancer	1.01e-05	8.96e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA1—stomach cancer	1.01e-05	8.96e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FBP1—stomach cancer	1.01e-05	8.96e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NDUFA2—stomach cancer	1.01e-05	8.96e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.01e-05	8.91e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLCE1—stomach cancer	1.01e-05	8.91e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK8—stomach cancer	9.98e-06	8.84e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APC—stomach cancer	9.96e-06	8.82e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CD44—stomach cancer	9.73e-06	8.62e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—UMPS—stomach cancer	9.65e-06	8.55e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLIN2—stomach cancer	9.51e-06	8.42e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA2—stomach cancer	9.25e-06	8.19e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6R—stomach cancer	9.25e-06	8.19e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—STAT3—stomach cancer	9.12e-06	8.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NT5E—stomach cancer	9.01e-06	7.98e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PGAM1—stomach cancer	9.01e-06	7.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PDHA1—stomach cancer	8.97e-06	7.94e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ECHS1—stomach cancer	8.97e-06	7.94e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK3—stomach cancer	8.72e-06	7.72e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SERPINE1—stomach cancer	8.66e-06	7.67e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDH7A1—stomach cancer	8.6e-06	7.62e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLCE1—stomach cancer	8.6e-06	7.62e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FADS1—stomach cancer	8.43e-06	7.47e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TYMP—stomach cancer	8.43e-06	7.47e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RHOA—stomach cancer	8.35e-06	7.4e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK1—stomach cancer	8.29e-06	7.35e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—EGFR—stomach cancer	8.29e-06	7.34e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPP2R1A—stomach cancer	8.27e-06	7.33e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—stomach cancer	8.27e-06	7.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—UMPS—stomach cancer	8.24e-06	7.3e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTP1—stomach cancer	8.12e-06	7.19e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—stomach cancer	8e-06	7.09e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SREBF2—stomach cancer	7.9e-06	6.99e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—KRAS—stomach cancer	7.83e-06	6.94e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—RORA—stomach cancer	7.8e-06	6.91e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ERBB2—stomach cancer	7.73e-06	6.85e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PDHA1—stomach cancer	7.66e-06	6.79e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ECHS1—stomach cancer	7.66e-06	6.79e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TYMS—stomach cancer	7.54e-06	6.68e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTM1—stomach cancer	7.46e-06	6.61e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—stomach cancer	7.33e-06	6.5e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDOB—stomach cancer	7.31e-06	6.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FADS1—stomach cancer	7.21e-06	6.38e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TYMP—stomach cancer	7.21e-06	6.38e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PIK3CA—stomach cancer	7.2e-06	6.37e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDKN1B—stomach cancer	7.16e-06	6.34e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ERCC2—stomach cancer	7.01e-06	6.21e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.9e-06	6.11e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.88e-06	6.09e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCND1—stomach cancer	6.83e-06	6.05e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—JUN—stomach cancer	6.82e-06	6.04e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALOX5—stomach cancer	6.8e-06	6.02e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SREBF2—stomach cancer	6.75e-06	5.98e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DPYD—stomach cancer	6.69e-06	5.92e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—RORA—stomach cancer	6.67e-06	5.91e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HRAS—stomach cancer	6.66e-06	5.9e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—stomach cancer	6.63e-06	5.88e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDKN1A—stomach cancer	6.61e-06	5.85e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—stomach cancer	6.59e-06	5.84e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK8—stomach cancer	6.45e-06	5.71e-05	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—stomach cancer	6.37e-06	5.64e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDOB—stomach cancer	6.25e-06	5.53e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAV1—stomach cancer	6.08e-06	5.38e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOA1—stomach cancer	6.07e-06	5.37e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.06e-06	5.37e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—stomach cancer	5.96e-06	5.28e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTT1—stomach cancer	5.91e-06	5.24e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT3—stomach cancer	5.9e-06	5.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.89e-06	5.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.88e-06	5.21e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2A6—stomach cancer	5.85e-06	5.18e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALOX5—stomach cancer	5.81e-06	5.15e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DPYD—stomach cancer	5.71e-06	5.06e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1C3—stomach cancer	5.69e-06	5.04e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK3—stomach cancer	5.63e-06	4.99e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ENO1—stomach cancer	5.54e-06	4.91e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MYC—stomach cancer	5.48e-06	4.85e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.45e-06	4.83e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK1—stomach cancer	5.36e-06	4.75e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EGFR—stomach cancer	5.36e-06	4.75e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—stomach cancer	5.34e-06	4.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.18e-06	4.59e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KRAS—stomach cancer	5.06e-06	4.49e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTT1—stomach cancer	5.05e-06	4.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2A6—stomach cancer	5e-06	4.42e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CD44—stomach cancer	4.91e-06	4.35e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.86e-06	4.3e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—stomach cancer	4.81e-06	4.26e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.77e-06	4.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ENO1—stomach cancer	4.74e-06	4.19e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.66e-06	4.13e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PIK3CA—stomach cancer	4.65e-06	4.12e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—stomach cancer	4.6e-06	4.07e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—stomach cancer	4.5e-06	3.99e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HRAS—stomach cancer	4.3e-06	3.81e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—stomach cancer	4.2e-06	3.72e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CD44—stomach cancer	4.2e-06	3.72e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.18e-06	3.7e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—stomach cancer	4.12e-06	3.65e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTP1—stomach cancer	4.1e-06	3.63e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.07e-06	3.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—stomach cancer	4.04e-06	3.58e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TYMS—stomach cancer	3.81e-06	3.38e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTM1—stomach cancer	3.77e-06	3.34e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.57e-06	3.16e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ERCC2—stomach cancer	3.54e-06	3.14e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTP1—stomach cancer	3.5e-06	3.1e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—stomach cancer	3.45e-06	3.06e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—stomach cancer	3.33e-06	2.95e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TYMS—stomach cancer	3.26e-06	2.88e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTM1—stomach cancer	3.22e-06	2.85e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAV1—stomach cancer	3.07e-06	2.72e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOA1—stomach cancer	3.06e-06	2.71e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ERCC2—stomach cancer	3.03e-06	2.68e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.93e-06	2.6e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—stomach cancer	2.84e-06	2.52e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—stomach cancer	2.7e-06	2.39e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAV1—stomach cancer	2.62e-06	2.32e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOA1—stomach cancer	2.62e-06	2.32e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PIK3CA—stomach cancer	2.59e-06	2.29e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.51e-06	2.22e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—stomach cancer	2.43e-06	2.15e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—stomach cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—stomach cancer	2.31e-06	2.04e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—stomach cancer	2.12e-06	1.88e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—stomach cancer	2.07e-06	1.84e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—stomach cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—stomach cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.12e-06	9.89e-06	CbGpPWpGaD
